ARE NEUROPHYSIOLOGICAL PARAMETERS AN OBJECTIVE MEASURE OF DISEASE STATUS AND PROGRESSION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS?

被引：0
作者：
Witherick, J.
Kane, N.
Butler, S.
Walsh, P.
Blake, K.
Faulkner, H.
Burrows, J.
Inglis, K.
Cottrell, D.
机构：
[1] N Bristol NHS Trust, Frenchay Hosp, Dept Neurol, Bristol, Avon, England
[2] N Bristol NHS Trust, Frenchay Hosp, Dept Neurophysiol, Bristol, Avon, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2012年 / 83卷 / 03期
关键词：
D O I：
10.1136/jnnp-2011-301993.194
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Primary Progressive Multiple Sclerosis in the ORATORIO Trial
    Wolinsky, Jerry
    Montalban, Xavier
    Kappos, Ludwig
    Hauser, Stephen
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bemasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Arnold, Douglas
    NEUROLOGY, 2017, 88
  • [32] EVALUATION OF NO EVIDENCE OF PROGRESSION OR ACTIVE DISEASE (NEPAD) IN PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN THE ORATORIO TRIAL
    Wolinsky, Jerry
    Montalban, Xavier
    Kappos, Ludwig
    Hauser, Stephen
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bernasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Arnold, Doug L.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05)
  • [33] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Montalban, X.
    Wolinsky, J.
    Kappos, L.
    Hauser, S. L.
    Giovannoni, G.
    de Seze, J.
    Bar-or, A.
    Masterman, D.
    Bernasconi, C.
    Wei, W.
    Garren, H.
    Chin, P.
    Belachew, S.
    Arnold, D. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 576 - 576
  • [34] APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis
    Losonczi, Erika
    Bencsik, Krisztina
    Nagy, Zsanett Fricska
    Honti, Viktor
    Szalczer, Estilla
    Rajda, Cecilia
    Illes, Zsolt
    Matyas, Klotild
    Rozsa, Csilla
    Csepany, Tuende
    Fuevesi, Judit
    Vecsei, Laszlo
    SWISS MEDICAL WEEKLY, 2010, 140 : 29
  • [35] Objective classification of multiple sclerosis disease course results in frequent reclassification to secondary progressive multiple sclerosis
    Hillert, Jan
    Forsberg, Lars
    Manouchehrinia, Ali
    Ramanujam, Ryan
    Spelman, Timothy
    Klyve, Pernilla
    Drahota, Jiri
    Horakova, Dana
    Joensen, Hanna
    Magyari, Melinda
    Ellenberger, David
    Stahmann, Alexander
    Van der Walt, Anneke
    Rodgers, Jeff
    Witts, James A.
    Middleton, Rod
    Nicholas, Richard
    Bezlyak, Vladimir
    Adlard, Nicholas
    Hach, Thomas
    Lines, Carol
    Glaser, Anna
    NEUROLOGY, 2021, 96 (15)
  • [36] Neurophysiological and behavioural correlates of ocrelizumab therapy on manual dexterity in patients with primary progressive multiple sclerosis
    Raffaele Dubbioso
    Marco Bove
    Daniele Boccia
    Vincenzo D’Ambrosio
    Maria Nolano
    Fiore Manganelli
    Rosa Iodice
    Journal of Neurology, 2022, 269 : 4791 - 4801
  • [37] Neurophysiological and behavioural correlates of ocrelizumab therapy on manual dexterity in patients with primary progressive multiple sclerosis
    Dubbioso, Raffaele
    Bove, Marco
    Boccia, Daniele
    D'Ambrosio, Vincenzo
    Nolano, Maria
    Manganelli, Fiore
    Iodice, Rosa
    JOURNAL OF NEUROLOGY, 2022, 269 (09) : 4791 - 4801
  • [38] Disease onset in familial and sporadic primary progressive multiple sclerosis
    Koch, M.
    Zhao, Y.
    Yee, I.
    Guimond, C.
    Kingwell, E.
    Rieckmann, P.
    Sadovnick, D.
    Tremlett, H.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (06) : 694 - 700
  • [39] Clinical predictors of disease progression in a cohort of Tunisian progressive Multiple Sclerosis
    Souissi, A.
    Mrabet, S.
    Nasri, A.
    Ben Djebara, M.
    Gargouri, A.
    Kacem, I.
    Gouider, R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [40] Cerebellar volume as an outcome measure in therapeutic trials of primary progressive multiple sclerosis
    Inglese, M.
    Petracca, M.
    Saiote, C.
    Ruggieri, S.
    Fabian, M.
    Howard, J.
    Riley, C.
    Krieger, S.
    Miller, A.
    Lublin, F.
    Sormani, M. P.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 198 - 199
12345